Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Durham, NC
SEC filing record 1 source field available
Fiscal year end
31 December
Opus Genetics, Inc. has filed 1,037 SEC EDGAR filings since 29 Apr 2003

SEC filing history

Showing 651-675 of 843 matching filings.

Per page
25
Current page
27
4

FORM 4

Filing date
01 Feb 2016
Reporting date
28 Jan 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
01 Feb 2016
Reporting date
28 Jan 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-79996

REXAHN PHARMACEUTICALS, INC.

Filing date
19 Jan 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-34079

REXAHN PHARMACEUTICALS, INC 8-K 11-12-2015

Filing date
12 Nov 2015
Reporting date
12 Nov 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-79996

REXAHN PHARMACEUTICALS, INC.

Filing date
10 Nov 2015
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-196255

REXAHN PHARMACEUTICALS, INC 424B5 11-6-2015

Filing date
10 Nov 2015
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-196255

REXAHN PHARMACEUTICALS, INC 424B5 11-5-2015

Filing date
06 Nov 2015
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-34079

REXAHN PHARMACEUTICALS, INC. 8-K 11-5-2015

Filing date
06 Nov 2015
Reporting date
05 Nov 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-34079

REXAHN PHARMACEUTICALS, INC. 8-K 11-5-2015

Filing date
05 Nov 2015
Reporting date
05 Nov 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 001-34079

REXAHN PHARMACEUTICALS, INC. 10-Q 9-30-2015

Filing date
02 Nov 2015
Reporting date
30 Sep 2015
Next action
Verify source filing
8-K File 001-34079

REXAHN PHARMACEUTICALS, INC 8-K 9-28-2015

Filing date
28 Sep 2015
Reporting date
28 Sep 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
18 Sep 2015
Reporting date
16 Sep 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
18 Sep 2015
Reporting date
16 Sep 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
18 Sep 2015
Reporting date
16 Sep 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
18 Sep 2015
Reporting date
16 Sep 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
18 Sep 2015
Reporting date
16 Sep 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-34079

REXAHN PHARMACEUTICALS, INC 8-K 9-10-2015

Filing date
10 Sep 2015
Reporting date
10 Sep 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 001-34079

REXAHN PHARMACEUTICALS, INC. 10-Q 6-30-2015

Filing date
07 Aug 2015
Reporting date
30 Jun 2015
Next action
Verify source filing
8-K File 001-34079

REXAHN PHARMACEUTICALS, INC 8-K 7-17-2015

Filing date
17 Jul 2015
Reporting date
17 Jul 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-34079

REXAHN PHARMACEUTICALS, INC 8-K 6-4-2015

Filing date
05 Jun 2015
Reporting date
04 Jun 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 001-34079

REXAHN PHARMACEUTICALS, INC. 10-Q 3-31-2015

Filing date
08 May 2015
Reporting date
31 Mar 2015
Next action
Verify source filing
ARS File 001-34079

AUTO-GENERATED PAPER DOCUMENT

Filing date
23 Apr 2015
Reporting date
31 Dec 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 001-34079

REXAHN PHARMACEUTICALS INC DEFA 14A 4-17-2015

Filing date
17 Apr 2015
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-34079

REXAHN PHARMACEUTICALS INC DEF14A 6-4-2015

Filing date
14 Apr 2015
Reporting date
04 Jun 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
PRE 14A File 001-34079

REXAHN PHARMACEUTICALS INC PRE 14A 6-4-2015

Filing date
30 Mar 2015
Reporting date
04 Jun 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .